Lv1
60 积分 2025-07-10 加入
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
9小时前
待确认
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
3个月前
已完结
HIIT may ameliorate inter-organ crosstalk between liver and hypothalamus of HFD-induced MAFLD rats; A two-phase study to investigate the effect of exercise intensity as a stressor
3个月前
已完结
Liver-specific actions of GH and IGF1 that protect against MASLD
5个月前
已完结
NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease
6个月前
已完结
The role of hypothalamus in the pathophysiological process of MASLD and advances in drug discovery
8个月前
已完结
Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults
11个月前
已完结
Prevalence of subclinical hypothyroidism and longitudinal thyroid stimulating hormone changes in youth with metabolic dysfunction-associated steatotic liver disease: an observational study
11个月前
已完结
皖公网安备34019202002308
